Jennifer R. Cochran - 12 Jul 2021 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
By: Charles S. Berkman For: Jennifer R. Cochran
Issuer symbol
LGND
Transactions as of
12 Jul 2021
Net transactions value
$0
Form type
4
Filing time
14 Jul 2021, 20:19:46 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Award $0 +1,161 $0.000000 1,161 12 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LGND Non-Qualified Stock Option (right to buy) Award $0 +4,508 $0.000000 4,508 12 Jul 2021 Common Stock 4,508 $126.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable in 3 successive annual installments upon completion of each calendar year of service beginning on the grant date.